Rivaroxaban (Xarelto)

FDA NEWS RELEASE

Nov 2, 2012

FDA expands use of Xarelto to treat, reduce recurrence of blood clots

"The U.S. Food and Drug Administration today expanded the approved use of Xarelto (rivaroxaban) to include treating deep vein thrombosis (DVT) or pulmonary embolism (PE), and to reduce the risk of recurrent DVT and PE following initial treatment."

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm326654.htm

*

XARELTO (Rivaroxaban)

http://www.anticoagulacion-oral.es/es/